Jump Financial’s Caribou Biosciences CRBU Stock Holding History

Jump Financial’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.7K	Buy	+12,460	New	+$21.4K	﹤0.01%	1806
2025 Q3	–	Sell	-14,207	Closed	-$17.9K	–	1840
2025 Q2	$17.9K	Buy	+14,207	New	+$14K	﹤0.01%	1721
2024 Q2	–	Sell	-11,954	Closed	-$61.4K	–	1872
2024 Q1	$61.4K	Buy	+11,954	New	+$73.7K	﹤0.01%	1823
2023 Q4	–	Sell	-92,204	Closed	-$441K	–	1859
2023 Q3	$441K	Buy	+92,204	New	+$572K	0.02%	1088
2023 Q2	–	Sell	-27,200	Closed	-$144K	–	1856
2023 Q1	$144K	Sell	27,200 -15,464	-36%	-$96.3K	0.01%	1379
2022 Q4	$268K	Buy	+42,664	New	+$380K	0.01%	1109
2022 Q2	–	Sell	-16,400	Closed	-$151K	–	1677
2022 Q1	$151K	Buy	+16,400	New	+$173K	0.01%	1358

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jump Financial's CRBU Position: Q1 2026 in Review

Jump Financial opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 12,460 shares worth $23.7K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings. This is a return to the name: Jump Financial previously reported a position in CRBU as recently as Q2 2025.

Jump Financial first reported a position in CRBU in Q1 2022 and has held it in 7 quarters since. The position peaked at $441K in Q3 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Jump Financial held 12,460 shares of Caribou Biosciences worth $23.7K as of Q1 2026.
Caribou Biosciences was a new Jump Financial position in Q1 2026.
Caribou Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1806 holding.
Jump Financial first reported a position in Caribou Biosciences in Q1 2022 and has held it in 7 quarters since.
Jump Financial's Caribou Biosciences position peaked at $441K in Q3 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.